Last reviewed · How we verify

NCT05502835

Pulse Pressure Variation Based Intraoperative Fluid Management Versus Traditional Fluid Management for Colonic Cancer Patients Undergoing Mass Resection and Anastomosis

Completed NA Last updated 30 January 2023
What this trial tests

NA trial testing pulse pressure variation in Intraoperative Fluid Volume in 90 participants. Completed in 25 January 2023.

Timeline
20 August 2022
Primary endpoint
20 January 2023
25 January 2023

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment90
Start date20 August 2022
Primary completion20 January 2023
Estimated completion25 January 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 70, any sex, with Intraoperative Fluid Volume or Hemodynamics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

pulse pressure variation based intraoperative fluid therapy versus traditional fluid therapy for colonic cancer patients undergoing mass resection and anastomosis for maintaining adequate hydration without complications.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pulse Pressure Variation-Based Intraoperative Fluid Management Versus Traditional Fluid Management for Colon Cancer Patients Undergoing Open Mass Resection and Anastomosis: A Randomized Controlled Trial.
    Mahrose R, Kasem AA. · · 2023 · cited 3× · PMID 38024002 · DOI 10.5812/aapm-135659

Verify or expand the search:

Other trials of pulse pressure variation

Trials testing the same drug.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05502835.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing